3 Buy-Rated Cannabis Stocks Under $10 to Scoop Up Now These three buy-rated cannabis stocks could be set to benefit as both leading presidential candidates show growing support for legalization. Barchart · Sep 16, 2024
2 Magnificent Growth Stocks to Buy Under $30 and Hold Forever Even a small investment in great stocks could yield significant long-term returns. Barchart · Aug 21, 2024
2 Growth Stocks With 64% to 152% Upside in 2024 These two stocks have been quietly making strides and could be long-term winners. Barchart · Jun 13, 2024
2 'Strong Buy' Cannabis Stocks Set to Gain on Spending Bill Maneuvers The U.S. cannabis market could be on the cusp of a critical growth catalyst, presenting ripe investment opportunities for those ready to navigate its unique risks. Barchart · Apr 23, 2024
Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy? Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed to impress with last quarter’s record revenue. Barchart · Mar 20, 2024
2 Growth Stocks With 32% to 77% Upside in 2024 While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run. Barchart · Mar 20, 2024
3 Cannabis Stocks Under $5 to Consider as the DEA Reviews Drug Status As the DEA reviews the federal classification of marijuana, here's what investors need to know about these three cannabis stocks under $5. Barchart · Jan 11, 2024
2 Growth Stocks With 35% to 150% Upside in 2024 While all eyes are on AI stocks, there are a few undervalued growth stocks that have the potential to provide investors with massive long-term returns. Barchart · Dec 27, 2023
3 Cannabis Stocks Analysts Like Better Than Canopy Growth Discover three cannabis stocks with significant growth potential, and learn why analysts favor these names over Canopy Growth. Barchart · Oct 13, 2023
Weed giants Columbia Care, Cresco Labs call off plans for $2 billion merger Cresco Labs and Columbia Care announced Monday the termination of a merger that was originally struck in 2022. Chicago Sun-Times · Aug 1, 2023
Chicago weed giant Cresco Labs claims in suit that competitor GTI poached a top-level employee A lawsuit filed this week in Cook County court claims a Cresco chemist resigned in May and quickly joined GTI, in violation of a one-year non-compete agreement. Chicago Sun-Times · Jul 21, 2023
Sean ‘Diddy’ Combs to buy Chicago-area cannabis operations in deal connected to $2 billion Cresco-Columbia Care merger Sean “Diddy” Combs has agreed to buy nine cannabis retail stores and three production facilities in Illinois, New York and Massachusetts for $185 million as part of required antitrust divestitures for the pending $2 billion Cresco-Columbia Care megamerger. Chicago Tribune · Nov 4, 2022
Cresco Labs Gains 'Firm Visibility' With Recent Asset Sales To Sean Diddy Combs Cresco Labs Inc (OTCMKTS: CRLBF) and Columbia Care Inc (OTCMKTS: CCHWF) announced the signing of definitive agreements to divest certain New York, Illinois, and Massachusetts assets to an entity owned and controlled by Benzinga · Nov 4, 2022
Sean ‘Diddy’ Combs to gain stake in cannabis trade The music and fashion mogul will acquire stores in Chicago and Villa Park and a growing operation in Aurora in a deal with Cresco Labs and Columbia Care. Chicago Sun-Times · Nov 4, 2022
Benzinga · Nov 4, 2022 Sean 'Diddy' To Buy Cannabis Assets From Cresco & Columbia Care, Creating The Largest Minority-Owned MSO Cresco Labs (OTCQX: CRLBF) (CSE:CL) and Columbia Care (OTCQX: CCHWF) (NEO:CCHW) (CSE:CCHW) announced the signing of definitive agreements to divest certain New York, Illinois, and Massachusetts
Chicago Tribune · Oct 31, 2022 A pastry chef and chemist combine talents to become a force in cannabis market through edibles CHICAGO — Award-winning Chicago pastry chef Mindy Segal can be viewed as a modern-day David, using a slingshot loaded with edibles infused with THC to slay the Goliath that is the pain and discomfort of a list of ailments including cancer and multiple sclerosis ... to name a few.
Benzinga · Oct 27, 2022 Cresco Labs Anticipates NYC's Massive Cannabis Demand With Strategic Move In Hudson Valley Cresco Labs (OTC: CRLBF) is redeveloping a former knife factory in Ulster County (two and a half hours from NYC), into a cannabis complex.
Benzinga · Oct 22, 2022 What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark.
Benzinga · Oct 17, 2022 Another Marijuana Firm Dumps A NY Cannabis Deal: Analyst Reveals Future Acquisition Targets And Their M&A Outlook Just days after Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) notified Goodness Growth Holdings, Inc. (CSE:GDNS) (OTCQX: GDNSF
Benzinga · Oct 7, 2022 Columbia Care: Updated Estimates Ahead Of Acquisition By Cresco Labs The Analyst
Benzinga · Sep 20, 2022 Where To Buy Legal Weed These Days: New Cannabis Shops & Products Curaleaf Bolsters PA Retail Footprint Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is expanding its Pennsylvaniaretail footprint with a new store in Allentown.
Benzinga · Sep 20, 2022 Cannabis Industry Report: House Brands Losing Ground in Massachusetts? As recreational markets mature, “house brands” are starting to lose share. What is the importance of branded cannabis flowers in this context? What are the macro trends that drive the evolution of the flower category? How does market segmentation impact this category and how do regulations affect market share across states?
Benzinga · Aug 18, 2022 'One Of Best-In-Class' Cannabis MSOs Has 'Optionality' When States Go Recreational, Bullish Analyst Says After Results Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove
Benzinga · Jul 26, 2022 Cannabis Chart of the Week: Is The SAFE+ Act Scaring Away The Shorts? Cannabis stocks have rallied over the last several weeks as discussion of the Schumer/Booker bill and the likelihood of a pivot to a SAFE+ Banking Act dominated the news. Articles in the press have made it seem as though short sellers had been vigorously covering their positions.
Benzinga · Jul 23, 2022 How To Get In Touch With The 5 Biggest Cannabis Operators In The US While there’s no doubt that the federal legalization of marijuana would make the industry explode, current trends shouldn’t be underestimated.